Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.

Cunningham EB, Hajarizadeh B, Amin J, Litwin AH, Gane E, Cooper C, Lacombe K, Hellard M, Read P, Powis J, Dalgard O, Bruneau J, Matthews GV, Feld JJ, Dillon JF, Shaw D, Bruggmann P, Conway B, Fraser C, Marks P, Dore GJ, Grebely J.

Clin Infect Dis. 2019 Nov 2. pii: ciz1089. doi: 10.1093/cid/ciz1089. [Epub ahead of print]

PMID:
31677262
2.

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study.

Artenie AA, Cunningham EB, Dore GJ, Conway B, Dalgard O, Powis J, Bruggmann P, Hellard M, Cooper C, Read P, Feld JJ, Hajarizadeh B, Amin J, Lacombe K, Stedman C, Litwin AH, Marks P, Matthews GV, Quiene S, Erratt A, Bruneau J, Grebely J.

Clin Infect Dis. 2019 Jul 11. pii: ciz633. doi: 10.1093/cid/ciz633. [Epub ahead of print]

PMID:
31300820
3.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA.

J Med Microbiol. 2019 Jul 2. doi: 10.1099/jmm.0.001032. [Epub ahead of print]

PMID:
31264957
4.

Which healthcare workers work with acute respiratory illness? Evidence from Canadian acute-care hospitals during 4 influenza seasons: 2010-2011 to 2013-2014.

Jiang L, McGeer A, McNeil S, Katz K, Loeb M, Muller MP, Simor A, Powis J, Kohler P, Di Bella JM, Coleman BL; Canadian Healthcare Worker Study Group.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):889-896. doi: 10.1017/ice.2019.141. Epub 2019 Jun 18.

PMID:
31208477
5.

Improving healthcare worker adherence to the use of transmission-based precautions through application of human factors design: a prospective multi-centre study.

Williams VR, Leis JA, Trbovich P, Agnihotri T, Lee W, Joseph B, Glen L, Avaness M, Jinnah F, Salt N, Powis JE.

J Hosp Infect. 2019 Sep;103(1):101-105. doi: 10.1016/j.jhin.2019.03.014. Epub 2019 Mar 30.

6.

Multilocus Variable-Number Tandem-Repeat Analysis of Clostridioides difficile Clusters in Ribotype 027 Isolates and Lack of Association with Clinical Outcomes.

Garneau JR, Abou Chakra CN, Fortier LC, Labbé AC, Simor AE, Gold W, Muller M, McGeer A, Powis J, Katz K, Pépin J, Valiquette L.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01724-18. doi: 10.1128/JCM.01724-18. Print 2019 May.

7.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.

Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.

PMID:
30616737
8.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.

Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Clin Infect Dis. 2019 Aug 30;69(6):970-979. doi: 10.1093/cid/ciy1009.

PMID:
30508064
9.

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.

Grebely J, Conway B, Cunningham EB, Fraser C, Moriggia A, Gane E, Stedman C, Cooper C, Castro E, Schmid P, Petoumenos K, Hajarizadeh B, Marks P, Erratt A, Dalgard O, Lacombe K, Feld JJ, Bruneau J, Daulouede JP, Powis J, Bruggmann P, Matthews GV, Kronborg I, Shaw D, Dunlop A, Hellard M, Applegate TL, Crawford S, Dore GJ; D3FEAT Study Group.

Int J Drug Policy. 2018 Dec;62:94-103. doi: 10.1016/j.drugpo.2018.10.004. Epub 2018 Oct 29.

PMID:
30384028
10.

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study.

Cunningham EB, Amin J, Feld JJ, Bruneau J, Dalgard O, Powis J, Hellard M, Cooper C, Read P, Conway B, Dunlop AJ, Norton B, Litwin AH, Hajarizadeh B, Thurnheer MC, Dillon JF, Weltman M, Shaw D, Bruggmann P, Gane E, Fraser C, Marks P, Applegate TL, Quiene S, Siriragavan S, Matthews GV, Dore GJ, Grebely J; SIMPLIFY study group.

Int J Drug Policy. 2018 Dec;62:14-23. doi: 10.1016/j.drugpo.2018.08.013. Epub 2018 Oct 22.

PMID:
30352330
11.

Using Dog Scent Detection as a Point-of-Care Tool to Identify Toxigenic Clostridium difficile in Stool.

Taylor MT, McCready J, Broukhanski G, Kirpalaney S, Lutz H, Powis J.

Open Forum Infect Dis. 2018 Aug 22;5(8):ofy179. doi: 10.1093/ofid/ofy179. eCollection 2018 Aug.

12.

Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1.

Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A; Toronto Invasive Bacterial Diseases Network (TIBDN).

Emerg Infect Dis. 2018 Sep;24(9):1674-1682. doi: 10.3201/eid2409.180164.

13.

From client to co-worker: a case study of the transition to peer work within a multi-disciplinary hepatitis c treatment team in Toronto, Canada.

Tookey P, Mason K, Broad J, Behm M, Bondy L, Powis J.

Harm Reduct J. 2018 Aug 14;15(1):41. doi: 10.1186/s12954-018-0245-7.

14.
15.

Evaluating Antimicrobial Use and Spectrum of Activity in Ontario Hospitals: Feasibility of a Multicentered Point Prevalence Study.

Leung V, Li M, Wu JH, Langford B, Zvonar R, Powis J, Longpre J, Béïque L, Gill S, Ho G, Garber G.

Open Forum Infect Dis. 2018 May 24;5(6):ofy110. doi: 10.1093/ofid/ofy110. eCollection 2018 Jun.

16.

Comparison of response rates on invitation mode of a web-based survey on influenza vaccine adverse events among healthcare workers: a pilot study.

Tai X, Smith AM, McGeer AJ, Dubé E, Holness DL, Katz K, McGillis Hall L, McNeil SA, Powis J, Coleman BL.

BMC Med Res Methodol. 2018 Jun 20;18(1):59. doi: 10.1186/s12874-018-0524-8.

17.

Using In-depth History Screening as an Additional Method to Help Delabel Inappropriate β-Lactam Allergies.

Vaisman A, McCready J, Powis J.

Clin Infect Dis. 2018 Nov 28;67(12):1959-1960. doi: 10.1093/cid/ciy480. No abstract available.

PMID:
29878079
18.

Immunogenicity and reactogenicity of high- vs. standard-dose trivalent inactivated influenza vaccine in healthcare workers: a pilot randomized controlled trial.

Volling C, Coleman BL, Katz K, Simor AE, Muller M, Powis J, McElhaney J, McGeer A.

Clin Microbiol Infect. 2019 Feb;25(2):217-224. doi: 10.1016/j.cmi.2018.05.002. Epub 2018 May 18.

PMID:
29783025
19.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
20.

Factors associated with influenza vaccination among healthcare workers in acute care hospitals in Canada.

Hussain H, McGeer A, McNeil S, Katz K, Loeb M, Simor A, Powis J, Langley J, Muller M; Canadian Health Care Worker Study Group, Coleman BL.

Influenza Other Respir Viruses. 2018 May;12(3):319-325. doi: 10.1111/irv.12545. Epub 2018 Mar 2.

21.

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6.

PMID:
29310928
22.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

23.

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada.

Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, Conway T, Webster K, de Pokomandy A, Loutfy MR, Anema A, Becker D, Brotto L, Carter A, Cardinal C, Colley G, Ding E, Duddy J, Gataric N, Hogg RS, Hosward T, Jabbari S, Jones E, Kestler M, Langlois A, Lima V, Lloyd-Smith E, Medjuck M, Miller C, Money D, Nicholson V, Ogilvie G, Patterson S, Pick N, Roth E, Salters K, Sanchez M, Sas J, Sereda P, Summers M, Tom C, Wang L, Webster K, Zhang W, Abdul-Noor R, Angel J, Barry F, Bauer G, Beaver K, Benoit A, Bertozzi B, Borton S, Bourque T, Brophy J, Burchell A, Carlson A, Cioppa L, Cohen J, Conway T, Cooper C, Cotnam J, Cousineau J, Fraleigh A, Gagnier B, Gasingirwa C, Greene S, Hart T, Islam S, Kaushic C, Kennedy L, Kerr D, Kiboyogo M, Kwaramba G, Leonard L, Lewis J, Logie C, Margolese S, Muchenje M, Ndungʼu M, OʼBrien K, Ouellette C, Powis J, Quan C, Raboud J, Rachlis A, Ralph E, Rourke S, Rueda S, Sandre R, Smaill F, Smith S, Tigere T, Tharao W, Walmsley S, Wobeser W, Yee J, Yudin M, Baril JG, Burke NB, Clément P, Dayle J, Dubuc D, Fernet M, Groleau D, Hot A, Klein M, Martin C, Massie L, Ménard B, OʼBrien N, Otis J, Peltier D, Pierre A, Proulx-Boucher K, Rouleau D, Savoie É, Tremblay C, Trottier B, Trottier S, Tsoukas C, Gahagan J, Hankins C, Masching R, Ogunnaike-Cooke S.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):144-153. doi: 10.1097/QAI.0000000000001589.

24.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.

Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators; Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators.

Influenza Other Respir Viruses. 2018 Mar;12(2):232-240. doi: 10.1111/irv.12521. Epub 2018 Jan 24.

25.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McElhaney JE, Ambrose A, Boivin G, Bowie W, Chit A, ElSherif M, Green K, Halperin S, Ibarguchi B, Johnstone J, Katz K, Langley J, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McGeer A, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN).

J Infect Dis. 2017 Aug 15;216(4):405-414. doi: 10.1093/infdis/jix282.

26.

Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada.

Mason K, Dodd Z, Guyton M, Tookey P, Lettner B, Matelski J, Sockalingam S, Altenberg J, Powis J.

Int J Drug Policy. 2017 Sep;47:202-208. doi: 10.1016/j.drugpo.2017.05.025. Epub 2017 Jun 12.

27.

Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial stewardship.

Vaisman A, McCready J, Hicks S, Powis J.

J Antimicrob Chemother. 2017 Sep 1;72(9):2657-2660. doi: 10.1093/jac/dkx171.

PMID:
28605452
28.

Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation.

Leis JA, Palmay L, Ho G, Raybardhan S, Gill S, Kan T, Campbell J, Kiss A, McCready JB, Das P, Minnema B, Powis JE, Walker SAN, Ferguson H, Wong B, Weber E.

Clin Infect Dis. 2017 Oct 1;65(7):1059-1065. doi: 10.1093/cid/cix512.

PMID:
28575226
29.

Every antibiotic, every day: Maximizing the impact of prospective audit and feedback on total antibiotic use.

Campbell TJ, Decloe M, Gill S, Ho G, McCready J, Powis J.

PLoS One. 2017 May 31;12(5):e0178434. doi: 10.1371/journal.pone.0178434. eCollection 2017.

30.

Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception.

Kennedy VL, Collins M, Yudin MH, Serghides L, Walmsley S, Angel JB, Ongoiba F, Powis J, Smaill F, Tharao W, Rachlis A, Silverman M, Sandre R, Regier DA, Loutfy M.

J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):239-246. doi: 10.1177/2325957416682089. Epub 2016 Dec 19.

PMID:
28485707
31.

Impact of two-step urine culture ordering in the emergency department: a time series analysis.

Stagg A, Lutz H, Kirpalaney S, Matelski JJ, Kaufman A, Leis J, McCready J, Powis J.

BMJ Qual Saf. 2018 Feb;27(2):140-147. doi: 10.1136/bmjqs-2016-006250. Epub 2017 May 3.

32.

Impact of a multifaceted antimicrobial stewardship program: A front-line ownership driven quality improvement project in a large urban emergency department.

Kaufman AJ, McCready J, Powis J.

CJEM. 2017 Nov;19(6):441-449. doi: 10.1017/cem.2017.11. Epub 2017 Apr 12.

PMID:
28399946
33.

Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada.

Coleman BL, Hassan K, Green K, Gubbay JB, Katz K, Mazzulli T, McNeil S, Muller M, Powis J, Richardson D, Simor A; TIBDN, McGeer AJ.

Antiviral Res. 2017 Apr;140:158-163. doi: 10.1016/j.antiviral.2017.01.025. Epub 2017 Feb 6.

PMID:
28179155
34.

Clarifying a "Penicillin" Allergy: A Teachable Moment.

Vaisman A, McCready J, Powis J.

JAMA Intern Med. 2017 Feb 1;177(2):269-270. doi: 10.1001/jamainternmed.2016.8185. No abstract available.

PMID:
28055069
35.

Legionella pneumonia in the Niagara Region, Ontario, Canada: a case series.

Cargnelli S, Powis J, Tsang JL.

J Med Case Rep. 2016 Dec 1;10(1):336.

36.

Predictors of influenza among older adults in the emergency department.

Lam PP, Coleman BL, Green K, Powis J, Richardson D, Katz K, Borgundvaag B, Smith-Gorvie T, Kwong JC, Bondy SJ, McGeer A.

BMC Infect Dis. 2016 Oct 28;16(1):615.

37.

Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback.

Kandel CE, Gill S, McCready J, Matelski J, Powis JE.

BMC Infect Dis. 2016 Jul 22;16:355. doi: 10.1186/s12879-016-1679-8.

38.

When Antimicrobial Stewardship Isn't Watching: The Educational Impact of Critical Care Prospective Audit and Feedback.

Fleming D, Ali KF, Matelski J, D'Sa R, Powis J.

Open Forum Infect Dis. 2016 May 30;3(3):ofw115. doi: 10.1093/ofid/ofw115. eCollection 2016 Sep.

39.

Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection.

Lapointe-Shaw L, Tran KL, Coyte PC, Hancock-Howard RL, Powis J, Poutanen SM, Hota S.

PLoS One. 2016 Feb 22;11(2):e0149521. doi: 10.1371/journal.pone.0149521. eCollection 2016.

40.

Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.

Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL, Johnstone J, Kitai I, Krajden S, Lovinsky R, Muller M, Powis J, Rau N, Walmsley S, Tyrrell G, Bitnun A, McGeer A; Toronto Invasive Bacterial Diseases Network.

Clin Infect Dis. 2016 Jan 15;62(2):139-47. doi: 10.1093/cid/civ803. Epub 2015 Sep 9.

PMID:
26354970
41.

Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.

Abou Chakra CN, McGeer A, Labbé AC, Simor AE, Gold WL, Muller MP, Powis J, Katz K, Garneau JR, Fortier LC, Pépin J, Cadarette SM, Valiquette L.

Clin Infect Dis. 2015 Dec 15;61(12):1781-8. doi: 10.1093/cid/civ749. Epub 2015 Sep 3.

42.
43.

Beyond viral response: A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support.

Mason K, Dodd Z, Sockalingam S, Altenberg J, Meaney C, Millson P, Powis J.

Int J Drug Policy. 2015 Oct;26(10):1007-13. doi: 10.1016/j.drugpo.2015.04.012. Epub 2015 Apr 29.

PMID:
26005037
44.

Possible infectious causes of spontaneous splenic rupture: a case report.

Lam GY, Chan AK, Powis JE.

J Med Case Rep. 2014 Nov 30;8:396. doi: 10.1186/1752-1947-8-396.

45.

Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance.

Kuster SP, Rudnick W, Shigayeva A, Green K, Baqi M, Gold WL, Lovinsky R, Muller MP, Powis JE, Rau N, Simor AE, Walmsley SL, Low DE, McGeer A; Toronto Invasive Bacterial Diseases Network.

Clin Infect Dis. 2014 Oct;59(7):944-52. doi: 10.1093/cid/ciu497. Epub 2014 Jun 27.

PMID:
24973312
46.

Optimizing urine culture collection in the emergency department using frontline ownership interventions.

Chironda B, Clancy S, Powis JE.

Clin Infect Dis. 2014 Oct;59(7):1038-9. doi: 10.1093/cid/ciu412. Epub 2014 May 30. No abstract available.

PMID:
24879784
47.

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

McNeil S, Shinde V, Andrew M, Hatchette T, Leblanc J, Ambrose A, Boivin G, Bowie W, Diaz-Mitoma F, Elsherif M, Green K, Haguinet F, Halperin S, Ibarguchi B, Katz K, Langley J, Lagace-Wiens P, Light B, Loeb M, McElhaney J, Mackinnon-Cameron D, McCarthy A, Poirier M, Powis J, Richardson D, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McGeer A; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network; Toronto Invasive Bacterial Diseases Network (TIBDN).

Euro Surveill. 2014 Mar 6;19(9). pii: 20729.

48.

Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals.

Tadros M, Williams V, Coleman BL, McGeer AJ, Haider S, Lee C, Iacovides H, Rubinstein E, John M, Johnston L, McNeil S, Katz K, Laffin N, Suh KN, Powis J, Smith S, Taylor G, Watt C, Simor AE.

PLoS One. 2013 Sep 17;8(9):e75171. doi: 10.1371/journal.pone.0075171. eCollection 2013.

49.

A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.

Sockalingam S, Blank D, Banga CA, Mason K, Dodd Z, Powis J.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1377-84. doi: 10.1097/MEG.0b013e3283624a28.

PMID:
23680911
50.

Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations.

Win LL, Powis J, Shah H, Feld JJ, Wong DK.

Case Reports Hepatol. 2013;2013:454897. doi: 10.1155/2013/454897. Epub 2013 Jul 29.

Supplemental Content

Support Center